Retrospective analysis of efficacy and safety of oral paclitaxel for treatment of various cancers in dogs (2017–2021)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Retrospective analysis of efficacy and safety of oral paclitaxel for treatment of various cancers in dogs (2017–2021)

Published:2022-05-27 Issue:4 Volume:8 Page:1443-1450
ISSN:2053-1095
Container-title:Veterinary Medicine and Science
language:en
Short-container-title:Veterinary Medicine & Sci

Author:

Chae Hyung‐Kyu¹^ORCID,Oh Ye‐In¹,Park Sumin¹,An Ju‐Hyun¹,Seo Kyoungwon¹^ORCID,Kang Kyuyong²,Chu Seung‐nam³,Youn Hwa‐Young¹^ORCID

Affiliation:

1. Laboratory of Veterinary Internal Medicine, College of Veterinary Medicine Seoul National University Seoul Republic of Korea

2. College of Veterinary Medicine and the Research Institute for Veterinary Science Seoul National University Seoul Republic of Korea

3. DaeHwa Pharmaceutical Co. Ltd. Pangyo Research Laboratory Sungnam Republic of Korea

Publisher

Wiley

Subject

General Veterinary

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/vms3.829

Reference28 articles.

1. Paclitaxel in Advanced Non-Small Cell Lung Cancer

2. The pharmacological bases of the antiangiogenic activity of paclitaxel

3. Use of oral paclitaxel for the treatment of bladder tumors in dogs

4. Paclitaxel (Taxol®): A success story with valuable lessons for natural product drug discovery and development

5. Metronomic oral paclitaxel shows anti-tumor effects in an orthotopic mouse model of ovarian cancer

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-cancer effects of DHP107 on canine mammary gland cancer examined through in-vitro and in-vivo mouse xenograft models;BMC Veterinary Research;2024-01-03

2. Derivation of a new model of lung adenocarcinoma using canine lung cancer organoids for translational research in pulmonary medicine;Biomedicine & Pharmacotherapy;2023-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3